persist
infect
human
cytomegaloviru
hcmv
wide
preval
human
popul
mostli
asymptomat
immunocompet
individu
howev
hcmv
caus
diseas
upon
immunosuppress
hcmv
frequent
infecti
caus
congenit
defect
hear
loss
reason
vaccin
develop
hcmv
given
high
prioriti
multipl
approach
tri
far
limit
success
due
uniqu
immunogen
cell
program
potenti
recombin
cmv
also
shown
great
promis
vaccin
vector
chronic
infect
hiv
nonhuman
primat
model
clinic
develop
hcmvbase
vector
way
develop
vaccin
hcmv
vaccin
base
hcmv
well
virolog
immunolog
studi
vitro
vivo
requir
genet
manipul
cmv
genom
howev
larg
size
cmv
genom
kb
render
genet
challeng
initi
recombin
cmv
gener
marker
rescu
vivo
recombin
overlap
cosmid
howev
techniqu
supersed
clone
cmv
bacteri
artifici
chromosom
bac
allow
genet
manipul
complet
cmv
genom
escherichia
coli
bac
clone
gener
replac
genom
region
nonessenti
growth
tissu
cultur
bacteri
origin
replic
togeth
select
marker
use
vivo
recombin
infect
fibroblast
upon
transform
bac
e
coli
delet
region
reinsert
thu
gener
fulllength
viral
genom
contain
bac
cassett
recombin
viru
reconstitut
upon
transfect
bac
healthi
diploid
fibroblast
cell
follow
recombinasemedi
excis
bac
cassett
leav
loxp
scar
genom
although
bac
recombin
revolution
genet
manipul
larg
dna
viru
genom
sever
disadvantag
remain
first
foremost
bac
clone
requir
extens
viru
passag
tissu
cultur
sinc
insert
bac
cassett
subsequ
select
recombin
still
use
tradit
marker
rescu
method
procedur
prevent
direct
clone
hcmv
genom
dna
isol
clinic
sampl
rapidli
select
viral
subpopul
viral
mutant
adapt
growth
tissu
cultur
sinc
recent
work
reveal
astound
divers
hcmv
genom
infect
individu
requir
tissu
cultur
limit
abil
character
individu
clone
within
swarm
genom
result
rel
hcmv
genom
clone
bac
origin
bac
clone
show
typic
sign
tissu
cultur
adapt
furthermor
restor
actual
sequenc
present
primari
isol
often
requir
multipl
sequenti
clone
step
recent
advanc
assembl
edit
larg
dna
fragment
entir
bacteri
genom
synthet
biolog
method
enabl
microbi
genom
engin
unpreced
scale
scope
sever
bacteri
genom
clone
maintain
saccharomyc
cerevisia
complet
synthet
version
entir
chromosom
sever
mycoplasma
speci
assembl
dna
fragment
synthet
biolog
approach
thu
take
advantag
uniqu
abil
cerevisia
captur
reliabl
join
dna
fragment
entir
heterolog
chromosom
success
maintain
yeast
artifici
chromosom
yac
particularli
use
direct
clone
dna
given
sampl
transformationassoci
recombin
tar
clone
linear
dna
contain
yeast
plasmid
flank
sequenc
homolog
target
sequenc
transform
togeth
target
sequenc
upon
recombin
vivo
target
sequenc
contain
within
yeast
plasmid
explor
use
tar
clone
directli
clone
genom
fragment
hcmv
dna
prepar
limit
passag
tissu
cultur
follow
assembl
fulllength
genom
saccharomyc
cerevisia
test
case
use
earliest
avail
passag
hcmv
isol
toledo
lowpassagenumb
isol
ever
use
experiment
infect
human
toledo
isol
congenit
infect
child
fourth
passag
initi
character
seroposit
individu
later
use
infect
seroneg
individu
individu
previous
vaccin
serial
passag
town
strain
instanc
clear
immunolog
clinic
sign
infect
well
superinfect
consist
toledo
repres
fulli
infecti
hcmv
isol
repres
circul
strain
howev
clone
sequenc
fulllength
genom
toledo
bac
reveal
compar
primari
isol
toledo
display
genom
invers
delet
consist
tissu
cultur
adapt
demonstr
lowpassagenumb
isol
toledo
repres
mixtur
fibroblastadapt
version
parent
sequenc
use
tar
clone
gener
version
toledo
demonstr
parent
viru
vitro
vivo
hallmark
primari
isol
compar
primari
isol
bacclon
hcmv
toledo
display
invers
socal
ulb
region
frequent
mutat
upon
multipl
passag
hcmv
specif
bacclon
toledo
display
invers
result
recombin
event
within
sequenc
locat
one
end
end
fig
recombin
event
led
truncat
chemokinelik
protein
subunit
pentamer
complex
pentamer
complex
promot
infect
endotheli
epitheli
myeloid
cell
mutat
nonessenti
subunit
select
upon
passag
fibroblast
presum
due
fact
pentamerdefici
virus
less
cell
associ
sinc
pentamer
complex
mutant
nonhuman
primat
cmv
attenu
vivo
fibroblast
adapt
odd
clinic
observ
volunt
inocul
toledo
isol
therefor
determin
whether
earli
passag
toledo
alreadi
contain
delet
isol
dna
supernat
fibroblast
infect
toledo
passag
earliest
passag
still
avail
perform
diagnost
pcr
gene
adjac
nativ
versu
invert
configur
hcmv
isol
tr
use
control
adjac
wherea
adjac
indic
appropri
pcr
fragment
fig
interestingli
fragment
also
amplifi
toledo
indic
noninvert
genom
orient
similar
tr
addit
toledo
also
contain
genom
invert
configur
adjac
adjac
fig
thu
earli
passag
toledo
use
clinic
trial
consist
mixtur
wildtyp
fibroblastadapt
genom
configur
examin
genom
content
lowpassagenumb
toledo
sampl
unbias
fashion
employ
illumina
hiseq
pairedend
sequenc
viral
dna
isol
supernat
fibroblast
infect
toledo
depth
sequenc
coverag
suffici
obtain
fulllength
sequenc
major
sequenc
repres
fibroblastadapt
toledo
strain
minor
presum
parent
wildtyp
sequenc
refer
fibroblastadapt
toledo
strain
presum
parent
wildtyp
strain
toledof
toledop
respect
toledof
mostli
ident
toledo
sequenc
deposit
genbank
genbank
access
number
howev
singl
nucleotid
polymorph
snp
identifi
synonym
mutat
see
fig
supplement
materi
snp
either
due
sequenc
error
genbank
sequenc
mutat
occur
passag
clone
toledo
isol
order
model
sequenc
toledop
genom
toledof
genom
edit
refer
genom
sequenc
genbank
access
number
base
sequenc
result
individu
snp
alloc
either
one
toledo
genom
base
follow
criteria
variat
homogen
appli
genom
variat
heterogen
major
allel
appli
fibroblastadapt
genom
minor
allel
appli
parent
genom
usual
heterogen
variat
one
allel
would
match
allel
refer
genom
appli
would
take
action
deriv
genom
locu
align
fulllength
sequenc
toledof
toledop
reveal
addit
invers
fragment
flank
two
small
delet
toledof
infram
delet
gene
previous
report
insert
intergen
region
well
sever
snp
ul
region
fig
b
compar
sequenc
coverag
number
read
toledof
versu
toledop
snp
loci
abl
estim
ratio
two
sequenc
viral
dna
prepar
toledof
genom
repres
vast
major
sequenc
wherea
read
belong
toledop
fig
sinc
two
genom
sequenc
detect
sampl
highli
like
repres
intermedi
mixtur
cultur
taken
fastergrow
fibroblastadapt
variant
origin
isol
remain
similar
observ
report
upon
serial
passag
primari
isol
merlin
mutat
occur
within
three
passag
mutat
region
upon
subsequ
passag
sinc
clinic
studi
perform
passag
toledo
data
also
suggest
percentag
nonfibroblastadapt
wildtyp
sequenc
like
higher
although
passag
sampl
remain
make
imposs
determin
exact
composit
observ
presenc
differ
variant
within
given
primari
isol
illustr
typic
challeng
clone
hcmv
genom
continu
passag
toledo
like
result
presenc
toledof
popul
two
independ
deriv
bac
clone
correspond
toledof
moreov
four
differ
chimera
hcmv
toledo
clone
overlap
cosmid
vaccin
strain
hcmv
town
exclus
base
toledof
might
explain
limit
infect
immunogen
clinic
studi
enabl
clone
primari
isol
limit
propag
tissu
cultur
therefor
use
toledo
sampl
test
case
new
tar
cloningbas
strategi
applic
hcmv
isol
gener
fig
align
number
known
hcmv
isol
identifi
highli
conserv
sequenc
use
design
synthet
tar
hook
tabl
clone
entir
genom
overlap
fragment
tabl
pair
adjac
tar
hook
flank
region
insert
yeast
centromer
plasmid
bac
sequenc
ycpbac
transform
yeast
togeth
shear
hcmv
toledo
dna
fig
fragment
contain
bp
homolog
adjac
fragment
well
flank
iscei
site
character
pcr
restrict
analysi
shown
fragment
fig
effici
clone
hcmv
fragment
rang
sinc
multipl
attempt
obtain
fulllength
genom
overlap
dna
fragment
fail
assembl
fulllength
hcmv
toledo
two
step
first
step
gener
two
half
genom
cotransform
overlap
dna
fragment
fragment
togeth
ycpbac
vector
cerevisia
fig
result
half
genom
also
transfer
e
coli
character
pcr
analysi
fig
assembl
half
genom
effici
posit
result
observ
clone
screen
gener
fulllength
genom
half
genom
releas
ycpbac
iscei
paci
restrict
digest
transform
togeth
linear
ycpbac
contain
tar
hook
begin
end
hcmv
genom
tabl
result
fulllength
genom
cerevisia
analyz
junction
pcr
analysi
fig
posit
clone
transform
e
coli
success
rate
assembl
fulllength
toledof
genom
yeast
approxim
transfer
fulllength
genom
e
coli
close
effici
nextgener
sequenc
analysi
show
tarassembl
hcmv
genom
ident
toledof
sequenc
present
lowpassagenumb
sampl
fig
assembl
toledop
genom
also
took
advantag
abil
simultan
chang
sequenc
fragment
either
mutagenesi
gene
synthesi
major
differ
toledop
toledof
locat
three
fragment
fragment
contain
sequenc
fragment
contain
open
read
frame
orf
fragment
contain
region
also
four
snp
differ
toledop
toledof
fig
howev
sinc
either
occur
noncod
region
synonym
modifi
assembl
toledop
correspond
toledop
sequenc
gener
vitro
digest
follow
assembl
pcr
fragment
contain
toledop
sequenc
fig
modifi
contain
appropri
toledop
sequenc
first
amplifi
invert
region
primer
contain
addit
sequenc
toledop
also
contain
sequenc
restor
proper
orient
region
ycpbac
remain
toledo
sequenc
also
amplifi
two
fragment
assembl
util
gibson
assembl
sgidna
transform
e
coli
result
tar
plasmid
sequenc
confirm
respect
toledop
fragment
gener
data
shown
fulllength
toledop
genom
gener
two
half
genom
toledop
fragment
replac
correspond
toledof
fragment
assembl
fulllength
toledop
genom
yeast
transfer
e
coli
robust
toledof
yeast
toledop
clone
correct
compar
toledof
effici
toledop
fulllength
genom
transfer
e
coli
compar
almost
toledop
reason
rel
ineffici
toledop
yet
understood
result
fulllength
ycpbac
contain
toledop
genom
analyz
nextgener
sequenc
ng
fig
c
except
four
snp
repair
henc
occur
assembl
viru
sequenc
assembl
fulllength
toledop
ycpbac
correspond
minor
toledop
sequenc
toledo
sampl
tarclon
hcmv
toledo
genom
releas
ycpbac
restrict
enzym
digest
target
flank
restrict
site
paci
endonucleas
recov
viru
releas
fulllength
genom
transfect
fibroblast
passag
cell
purifi
viral
stock
gener
vitro
vivo
character
time
viral
dna
extract
hirt
method
sequenc
ng
comparison
toledop
viru
ycpbac
sequenc
reveal
frameshift
mutat
amino
acid
residu
amino
acid
residu
fig
c
frameshift
mutat
found
approxim
genom
respect
suggest
mutat
gene
region
rapidli
select
even
start
molecular
clone
howev
mutat
truncat
protein
like
inactiv
protein
frameshift
elimin
final
amino
acid
sinc
subunit
pentamer
complex
facilit
entri
nonfibroblast
cell
determin
whether
truncat
would
affect
anticip
abil
toledop
infect
endotheli
cell
multistep
growth
curv
multipl
infect
moi
cell
toledop
toledof
gener
compar
titer
viru
supernat
compar
kinet
fig
contrast
toledop
abl
grow
human
umbil
cord
endotheli
cell
huvec
wherea
toledof
grow
fig
data
suggest
toledop
retain
function
pentamer
complex
despit
truncat
previous
report
human
mous
model
primari
isol
hcmv
abl
establish
latenc
reactiv
upon
mobil
myeloid
cell
bone
marrow
contrast
laboratoryadapt
strain
ad
unabl
p
caposio
unpublish
observ
compar
toledop
toledof
model
engraft
null
nsg
mice
human
progenitor
cell
week
engraft
mice
infect
via
intraperiton
inject
human
fibroblast
infect
hcmv
tr
hcmv
toledop
hcmv
toledof
week
postinfect
mice
split
two
group
one
group
treat
granulocyt
colonystimul
factor
gcsf
see
materi
method
administ
intraperiton
mobil
human
monocytesmacrophag
week
mobil
mice
sacrif
total
dna
extract
spleen
liver
hcmv
genom
analyz
use
quantit
pcr
compar
gcsftreat
untreat
group
abl
detect
quantit
differ
viral
dna
load
spleen
liver
hcmv
tr
toledop
fig
contrast
increas
viral
genom
copi
observ
toledof
moreov
compar
hcmvtr
toledop
genom
copi
number
tend
lower
even
nonmobil
mice
infect
toledof
thu
toledop
toledof
strongli
differ
abil
establish
latenc
reactiv
vivo
toledop
behav
similarli
primari
isol
tr
model
wherea
toledof
resembl
laboratoryadapt
strain
like
ad
appli
synthet
biolog
tool
specif
tar
clone
abl
gener
molecular
clone
hcmv
largest
human
herpesviru
directli
dna
extract
primari
isol
limit
passag
vitro
thu
method
potenti
enabl
direct
clone
cmv
clinic
sampl
eg
viral
dna
isol
congenit
infect
infant
without
need
tissu
cultur
tar
hook
use
gener
genom
fragment
design
repres
highli
conserv
genom
sequenc
hcmv
genom
clone
method
howev
case
sequenc
mismatch
tar
hook
easili
modifi
accord
sequenc
result
obtain
dna
sampl
clone
method
also
appli
new
dna
viru
isol
vitro
cultur
condit
establish
probabl
due
larg
size
hcmv
genom
kb
presenc
termin
repeat
end
genom
unabl
recov
fulllength
genom
cotransform
fragment
instead
gener
two
half
genom
eight
fragment
combin
fulllength
genom
second
recombin
step
contrast
smaller
herpesviru
genom
like
herp
simplex
viru
assembl
one
step
tar
clone
thu
first
method
permit
direct
clone
herpesvir
genom
addit
synthes
individu
tar
fragment
method
use
gener
partial
fulli
synthet
hcmv
genom
synthet
viral
genom
success
assembl
individu
fragment
smaller
virus
eg
consensu
sever
acut
respiratori
syndrom
sar
coronaviru
genom
bat
howev
date
possibl
larg
dna
virus
due
lack
suitabl
technolog
parallel
chemic
synthesi
larg
dna
fragment
becom
feasibl
afford
assembl
synthet
hcmv
genom
individu
fragment
yeast
describ
ultim
enabl
construct
complet
synthet
genom
modifi
sequenc
fragment
independ
also
possibl
simultan
chang
multipl
genom
loci
exemplifi
reconstruct
toledop
sequenc
exchang
three
fragment
toledof
thu
variou
fulllength
genom
readi
transfect
assembl
fragment
week
ideal
condit
contrast
introduct
multipl
mutat
bac
technolog
requir
multipl
step
sequenti
mutagenesi
moreov
final
assembl
hcmv
genom
contain
heterolog
sequenc
releas
restrict
digest
wherea
remov
bac
cassett
cre
recombinas
leav
loxp
site
viral
genom
due
versatil
tarbas
clone
also
enabl
gener
hybrid
genom
eg
differ
cytomegaloviru
cmv
strain
speci
facilit
map
strain
speciesspecif
trait
fact
nativ
viral
dna
contain
residu
bacteri
sequenc
excis
ycpbac
prior
transfect
addit
facilit
recoveri
live
viru
without
need
genom
manipul
crebas
excis
bac
cassett
test
case
direct
clone
use
lowpassagenumb
isol
toledo
stori
viru
deriv
congenit
infect
boy
toledo
ohio
passag
four
hcmv
toledo
use
human
challeng
studi
clinic
trial
remain
exampl
experiment
infect
human
lowpassagenumb
hcmv
observ
hcmv
townevaccin
individu
well
natur
seroposit
individu
show
clinic
symptom
mild
mononucleosislik
syndrom
challeng
pfu
toledo
wherea
seroneg
individu
develop
symptom
dose
low
pfu
howev
light
deep
sequenc
analysi
show
toledo
isol
mixtur
intact
toledop
mutat
toledof
like
symptom
caus
intact
fraction
inoculum
suggest
actual
pfu
need
overcom
anticmv
immun
might
even
lower
signific
differ
toledop
toledof
abil
establish
persist
infect
vivo
support
experi
human
mice
toledof
bare
abl
establish
latenc
model
observ
increas
viral
genom
copi
number
upon
mobil
monocytesmacrophag
indic
reactiv
dissemin
contrast
similar
primari
isol
toledop
establish
robust
latenc
reactiv
upon
monocytemacrophag
mobil
abil
correl
extent
broader
cell
tropism
display
pentamerintact
hcmv
howev
also
possibl
invers
ulb
fragment
affect
gene
express
within
gene
locu
implic
viral
latenc
well
infect
endotheli
cell
thu
multipl
mutat
could
contribut
attenu
phenotyp
toledof
vivo
interestingli
toledop
rapidli
adapt
tissu
cultur
condit
mutat
two
gene
region
mutat
toledof
repair
toledop
ycpbac
thu
even
hcmv
toledop
recov
molecular
clone
intact
mutat
gene
rapidli
select
vitro
thu
seem
like
toledof
variant
present
within
initi
isol
result
random
mutat
select
upon
passag
vitro
rapid
select
mutat
nonessenti
pentam
subunit
intact
molecular
clone
well
document
lowpassagenumb
isol
merlin
work
demonstr
intact
viral
fc
receptor
limit
viral
propag
cell
type
mutant
select
upon
passag
thu
unless
condit
express
mutant
aris
vitro
contrast
mutant
aris
upon
passag
fibroblast
select
type
mutant
avoid
grow
viru
nonfibroblast
cell
epitheli
cell
maintain
genet
integr
repair
toledop
would
thu
requir
control
express
via
condit
promot
demonstr
merlin
howev
despit
accumul
mutat
major
viral
genom
passag
clear
differ
abil
toledop
infect
endotheli
cell
infect
monocytemacrophag
nsg
mice
one
possibl
explan
differ
due
residu
intact
viru
similar
situat
passag
isol
use
clinic
trial
altern
truncat
toledop
might
still
retain
pentam
function
possibl
support
mutat
studi
demonstr
limit
impact
ctermin
mutat
endotheli
cell
infect
clonal
separ
intact
versu
mutat
version
toledo
requir
distinguish
possibl
taken
togeth
data
thu
suggest
due
multipl
mutat
toledof
sever
limit
abil
establish
maintain
latent
infect
importantli
cosmid
clone
toledof
previous
use
gener
chimer
virus
town
vaccin
strain
order
gener
vaccin
strain
less
attenu
highli
passag
town
strain
howev
four
differ
chimer
virus
unabl
elicit
clinic
immunolog
symptom
hcmvseroposit
individu
dose
pfu
moreov
although
cell
respons
detect
seroneg
individu
inocul
two
chimera
cell
respons
weak
demonstr
typic
expans
effector
memori
cell
observ
cmv
infect
find
townetoledof
chimera
unabl
recapitul
immun
respons
natur
elicit
hcmv
correl
lack
toledof
reactiv
upon
monocyt
mobil
suggest
chimer
virus
like
unabl
establish
persist
infect
requir
elicit
maintain
effector
memori
modifi
individu
tar
fragment
toledop
possibl
design
new
gener
hcmv
toledobas
vaccin
vaccin
vector
goal
retain
abil
hcmv
elicit
last
effector
memori
introduc
safeti
featur
elimin
viral
pathogenesi
human
primari
embryon
lung
fibroblast
purchas
atcc
manassa
va
cultur
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
mm
hepe
mm
sodium
pyruv
mm
lalanylglutamin
mm
nonessenti
amino
acid
uml
penicillin
streptomycin
human
umbil
vein
endotheli
cell
huvec
purchas
lonza
cultur
endotheli
growth
medium
clonet
contain
fb
human
recombin
vascular
endotheli
growth
factor
vegf
basic
fibroblast
growth
factor
bfgf
human
epiderm
growth
factor
hegf
insulinlik
growth
factor
hydrocortison
ascorb
acid
heparin
gentamicin
amphotericin
b
highserum
medium
hcmv
isol
tr
deriv
origin
patient
aidsrel
hcmv
retin
hcmv
toledop
toledof
viral
dna
extract
e
coli
use
qiagen
midikit
digest
paci
electropor
cell
infecti
viru
produc
titer
viru
determin
plaqu
assay
cell
previous
describ
plasmid
previous
describ
supernat
fibroblast
infect
toledo
isol
passag
use
extract
viral
dna
use
qiaamp
minelut
viru
spin
kit
qiagen
hcmv
tr
dna
extract
kit
posit
control
two
microlit
viral
dna
amplifi
taq
master
mix
new
england
biolab
neb
use
follow
primer
indic
parenthes
region
diagnost
pcr
indic
thermocycl
paramet
min
follow
cycl
cycl
consist
min
viral
dna
isol
supernat
fibroblast
infect
toledo
describ
isol
dna
incub
shrimp
dnase
remov
host
dna
affymetrix
h
room
temperatur
shrimp
dnase
inactiv
incub
min
sampl
remov
quantit
pcr
qpcr
analysi
viral
dna
purifi
larger
remain
sampl
qiaamp
minelut
viru
spin
kit
qiagen
elut
buffer
qpcr
use
determin
remov
host
dna
viral
dna
use
sequenc
use
illumina
hiseq
pairedend
sequenc
sequenc
read
sort
barcod
trim
map
hcmv
toledo
genbank
access
number
use
clc
bio
qiagen
clcrefassemblelong
program
variat
extract
report
use
clc
bio
findvari
program
report
variat
manual
inspect
use
clc
bio
assemblyview
program
variat
lack
suffici
evid
lack
span
read
insuffici
highqual
coverag
discard
case
larg
structur
variat
analyz
report
manual
exampl
larg
invers
indel
termini
occur
low
frequenc
determin
bespok
bioinformat
method
partit
sequenc
read
base
presenc
absenc
junction
sequenc
reassembl
partit
read
separ
map
contig
back
refer
sequenc
toledof
toledop
assembl
toledof
reconstitut
toledof
assembl
toledop
reconstitut
toledop
align
geneiou
biomatt
ltd
auckland
new
zealand
use
phyml
packag
refer
strain
hcmv
toledo
genbank
access
number
avail
ncbi
identif
insert
delet
singl
nucleotid
polymorph
snp
cerevisia
strain
use
yeast
transform
grown
ypd
yeast
extract
pepton
dextros
medium
supplement
adenin
cerevisia
spheroplast
prepar
use
previous
describ
method
follow
modif
overnight
cultur
grown
optic
densiti
nm
kept
overnight
sorbitol
cell
harvest
resuspend
ml
spe
solut
sorbitol
sodium
phosphat
zymolyas
solut
cell
final
resuspend
ml
stc
solut
sorbitol
trishcl
dna
transformationassoci
recombin
tar
clone
assembl
ad
spheroplast
follow
addit
peg
solut
peg
mm
mm
trishcl
suspens
incub
room
temperatur
min
peg
solut
remov
cell
incub
min
so
medium
sorbitol
mm
yeast
extract
pepton
transform
yeast
spheroplast
plate
select
top
agar
sorbitol
vector
first
pcr
amplifi
use
templat
phusion
neb
neb
dna
polymeras
plasmid
contain
bacteri
artifici
chromosom
bac
yeast
centromer
plasmid
ycp
sequenc
replic
e
coli
yeast
primer
add
iscei
paci
restrict
site
flank
bp
hcmv
homolog
end
vector
backbon
pcr
product
digest
dpni
neb
prior
transform
viral
dna
isol
toledo
describ
shear
pipet
six
hundr
nanogram
viral
genom
dna
cotransform
ng
appropri
vector
yeast
spheroplast
transform
patch
synthet
dropout
medium
without
histidin
supplement
adenin
sdhi
plate
suffici
growth
select
transfer
mm
naoh
incub
min
lyse
yeast
cell
pcr
dna
lyse
yeast
use
appropri
detect
primer
see
tabl
supplement
materi
use
confirm
correct
junction
vector
hcmv
fragment
side
posit
tar
clone
candid
yeast
patch
ml
liquid
cultur
resuspend
water
contain
zymolyas
mp
bio
mgml
incub
h
fifti
microlit
sd
ad
solut
incub
min
follow
addit
potassium
acet
incub
ice
min
clarif
dna
supernat
precipit
isopropanol
resuspend
trisedta
te
buffer
isol
dna
electropor
e
coli
epicentr
thermo
fisher
compet
cell
dna
purifi
posit
transform
restrict
enzym
analysi
sequenc
cultur
tar
clone
e
coli
grown
dna
isol
purelink
hipur
plasmid
midiprep
kit
thermo
fisher
prior
assembl
clone
digest
iscei
heat
kill
releas
hcmv
fragment
assembl
hcmv
genom
perform
tar
assembl
yeast
two
step
first
half
genom
assembl
follow
vector
dna
amplifi
pcr
use
templat
either
r
stand
revers
f
stand
forward
tabl
primer
tabl
assembl
half
genom
ng
vector
dna
ng
dna
fragment
ad
spheroplast
transform
patch
plate
contain
synthet
dropout
medium
without
uracil
supplement
adenin
dna
screen
pcr
appropri
junction
respect
detect
primer
tabl
use
naoh
lysi
posit
half
genom
transform
e
coli
compet
cell
screen
pcr
confirm
appropri
junction
assembl
full
genom
half
genom
process
iscei
paci
endonucleas
describ
releas
fragment
vector
dna
amplifi
pcr
use
templat
primer
tabl
ten
nanogram
vector
dna
ng
half
genom
ad
assembl
spheroplast
transform
patch
onto
sdhi
plate
dna
screen
pcr
appropri
junction
respect
detect
primer
tabl
use
naoh
lysi
method
previous
mention
posit
clone
transform
e
coli
compet
cell
describ
screen
pcr
confirm
appropri
junction
singl
coloni
e
coli
alphaselect
gold
effici
biolin
harbor
construct
cultur
overnight
ml
lb
supplement
carbenicillin
teknova
starter
cultur
dilut
liter
antibioticsuppl
lb
broth
shaken
rpm
cultur
cool
iptg
ad
final
concentr
mm
induc
protein
express
protein
induc
overnight
refriger
incub
shake
rpm
cell
pellet
wash
phosphatebuff
salin
pb
ph
resuspend
volum
xtractor
buffer
supplement
edtafre
proteas
inhibitor
clontech
mg
lysozym
sigmaaldrich
u
benzonas
millipor
cell
suspens
gentli
rotat
h
prior
mechan
lysi
microfluid
microfluid
cell
debri
pellet
g
h
recombin
protein
purifi
supernat
use
histalon
column
clontech
accord
manufactur
instruct
purifi
protein
store
buffer
mm
kcl
mm
hepe
ph
mm
dithiothreitol
dtt
glycerol
concentr
mgml
chimer
synthet
guid
rna
sgrna
design
vitro
synthes
purifi
describ
previous
previous
assembl
hcmv
toledof
fragment
contain
within
e
coliyeast
shuttl
purifi
use
qiaprep
spin
miniprep
kit
qiagen
plasmidborn
genom
fragment
independ
digest
conjunct
two
sgrna
fragment
fragment
target
sequenc
underlin
liber
dna
fragment
roughli
bp
bp
respect
onehour
digest
perform
volum
contain
ng
plasmid
dna
grna
mm
spermidin
sigmaaldrich
mm
ambion
mm
hepe
mm
kcl
mm
dtt
mm
edta
protein
follow
digest
heat
inactiv
min
digest
dna
extract
ultrapur
phenolchloroformisoamyl
alcohol
volvol
ph
precipit
ethanol
resuspend
steril
water
dna
fragment
use
gener
toledop
insert
fragment
obtain
de
novosynthes
gblock
idt
toledop
fragment
insert
encod
insert
found
toledof
sequenc
convers
toledop
fragment
insert
remov
insert
found
toledof
dna
insert
contain
overlap
sequenc
homolog
region
upstream
downstream
digest
site
facilit
vitro
assembl
synthes
insert
fragment
mix
correspond
digest
product
molar
ratio
insertvector
coval
join
via
standard
gibson
assembl
reaction
sgidna
follow
assembl
construct
transform
e
coli
transformax
electrocompet
cell
epicentr
plate
select
media
transform
verifi
contain
new
insert
use
pcr
sanger
sequenc
prior
final
confirm
full
toledop
genom
sequenc
nextgener
sequenc
ng
ng
sequenc
data
indic
toledop
genom
contain
larg
genom
invers
flank
two
small
insert
bp
larg
invers
entir
contain
within
previous
gener
toledof
genom
fragment
util
primer
idt
end
genom
fragment
backbon
pcr
amplifi
togeth
e
coliyeast
shuttl
vector
second
pcr
invert
sequenc
amplifi
ultram
oligonucleotid
gener
invert
sequenc
indic
termin
insert
flank
overlap
sequenc
homolog
region
end
first
amplicon
pcr
perform
kod
xtreme
hot
start
dna
polymeras
millipor
use
toledof
genom
fragment
templat
accord
manufactur
specif
amplicon
digest
dpni
neb
purifi
use
qiaquick
pcr
purif
kit
qiagen
follow
purif
amplicon
mix
equal
molar
ratio
coval
join
via
standard
gibson
assembl
reaction
sgidna
follow
assembl
construct
transform
e
coli
transformax
electrocompet
cell
epicentr
plate
select
media
transform
verifi
contain
new
insert
use
pcr
sanger
sequenc
prior
final
confirm
full
toledop
genom
sequenc
ng
anim
studi
carri
strict
accord
recommend
american
associ
accredit
laboratori
anim
care
aaalac
protocol
approv
institut
anim
care
use
committe
number
oregon
health
scienc
univers
nodscid
nsg
mice
maintain
pathogenfre
facil
oregon
health
scienc
univers
accord
procedur
approv
institut
anim
care
use
committe
sex
anim
use
human
mice
gener
previous
describ
anim
week
engraft
treat
ngmous
lipopolysaccharid
lp
h
infect
via
intraperiton
inject
human
dermal
fibroblast
previous
infect
hcmv
tr
toledop
toledof
approxim
pfu
per
mous
control
group
engraft
mice
mock
infect
use
uninfect
fibroblast
week
postinfect
infect
mice
split
two
group
one
group
treat
granulocyt
colonystimul
factor
gcsf
mgml
amgen
use
subcutan
microosmot
pump
alzet
methylen
octahydrochlorid
plerixafor
administ
intraperiton
mobil
hematopoiet
progenitor
cell
hpc
remain
mice
serv
direct
comparison
effect
viru
reactiv
dissemin
follow
hpc
mobil
one
week
hpc
mobil
mice
sacrif
organ
harvest
sampl
pcr
frozen
rnalat
solut
store
subsequ
analysi
total
dna
extract
approxim
section
mous
spleen
liver
use
dnazol
kit
life
technolog
hcmv
genom
analyz
use
quantit
pcr
taqman
perform
total
dna
use
taqman
fastadv
pcr
master
mix
appli
biosystem
accord
manufactur
instruct
primer
probe
recogn
hcmv
use
quantifi
hcmv
genom
probe
cgagggagagcaagtt
forward
primer
revers
primer
probe
contain
fam
report
molecul
quencher
molecul
appli
biosystem
reaction
initi
use
taqman
fast
advanc
master
mix
appli
biosystem
activ
min
follow
cycl
cycl
consist
min
use
steponeplu
taqman
thermocycl
result
analyz
use
abi
stepon
softwar
data
analyz
use
statist
program
graphpad
prism
statist
signific
determin
use
twoway
analysi
varianc
follow
bonferroni
posttest
correct
p
valu
lower
consid
signific
genom
sequenc
toledof
toledop
well
assembl
toledof
toledop
submit
genbank
access
number
